Ding et al. [25] developed an “AFP − TBS (ATS)” prognostic model that incorporates TBS and AFP levels at the time of initial diagnosis before surgery and at the time of recurrence to predict post − recurrence survival following the initial resection of HCC. This evidence concerns the gene AFP and hepatocellular carcinoma.